FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Dalmau

Research Profile

Disorders

HIV Infections

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Spain

Physiology

Co-author Network

Publications

TOP 3
Mireia Arnedo; David Dalmau; Nell Eisenberg; Cecilia Ferreyra; Laurence Flevaud; Jose Maria Gatell; Laura Ibáñez; Angels Jaén; Samuel Khamadi; Paul Roddy; Elena Alonso
Monitoring HIV viral load in resource limited settings: still a matter of debate?
Cecilia Ferreyra; Laurence Flevaud; Ashimosi S Khamadi; Martha Kihara Mugendi; Matilu Mwau; Elena Alonso; Ana Alvarez; Mireia Arnedo; Andrea Bernasconi; David Dalmau; Nell Eisenberg; Paul Roddy; Elena Velilla; Oliver Yun; Pedro Pablo Palma
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.
Vicens Diaz-Brito; Pere Domingo; Felipe García; Josep M Gatell; Hernando Knobel; Agathe León; Joaquim Peraire; Joan Albert Arnaiz; Bonaventura Clotet; Anna Cruceta; David Dalmau
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Dalmau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mireia Arnedo; David Dalmau; Nell Eisenberg; Cecilia Ferreyra; Laurence Flevaud; Jose Maria Gatell; Laura Ibáñez; Angels Jaén; Samuel Khamadi; Paul Roddy; Elena Alonso
Monitoring HIV viral load in resource limited settings: still a matter of debate?
PloS one 2012;7(12):e47391.
2012: Cecilia Ferreyra; Laurence Flevaud; Ashimosi S Khamadi; Martha Kihara Mugendi; Matilu Mwau; Elena Alonso; Ana Alvarez; Mireia Arnedo; Andrea Bernasconi; David Dalmau; Nell Eisenberg; Paul Roddy; Elena Velilla; Oliver Yun; Pedro Pablo Palma
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.
PloS one 2012;7(11):e49834.
2012: Vicens Diaz-Brito; Pere Domingo; Felipe García; Josep M Gatell; Hernando Knobel; Agathe León; Joaquim Peraire; Joan Albert Arnaiz; Bonaventura Clotet; Anna Cruceta; David Dalmau
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine.
Antiviral therapy 2012;17(2):337-46.
2007: Josep Mallolas; José L Blanco; J Pich; Juan A Arnaiz; J M Peña; David Dalmau; Elisa De Lazzari; A Ochoa; Francesc Vidal; M A Ribas; Ferran Segura; Enric Pedrol; J Flores; Anna Cruceta; S Varea; José M Miró; Esteban Martínez; José M Gatell
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.
Revista clínica española 2007;207(9):427-32.
2007: María Peñaranda; Vicenç Falco; Antoni Payeras; Queralt Jordano; Adria Curran; Antonio Pareja-Bezares; Gloria Samperiz; David Dalmau; Esteban Ribera; Melcior Riera
Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(7):e82-7.
2007: Josep Mallolas; Jl Blanco; Pablo Labarga; Antonio Vergara; Antonio Ocampo; María Sarasa; Mireia Arnedo; Y López-Púa; J García; J Juega; Ana Guelar; Alberto Terrón; David Dalmau; I García; M Zárraga; Esteban Martínez; Xavier Carné; Tomás Pumarola; R Escayola; José M Gatell
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
HIV medicine 2007;8(4):226-33.
2007: Consuelo Viladés; Montserrat Broch; Montserrat Plana; Pere Domingo; Carlos Alonso-Villaverde; Enric Pedrol; Hernando Knobel; David Dalmau; Joaquim Peraire; Cristina Gutiérrez; Anna López; Maria Antonia Sambeat; Montserrat Olona; Felipe Garcia; Cristóbal Richart; José M Gatell; Francesc Vidal
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):132-8.
2007: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; María Leyes; Enric Pedrol; Lluís Force; Elisa De Lazzari; José M Gatell
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.
AIDS (London, England) 2007;21(3):367-9.
2006: Joaquim Peraire; Montserrat Broch; Pere Domingo; Enric Pedrol; David Dalmau; Hernando Knobel; Consuelo Viladés; Maria Antonia Sambeat; Cristóbal Richart; Francesc Vidal
Absence of CXCR4 C-terminal polymorphisms in HIV-1-infected and uninfected Spaniards.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):382-3.
2006: Anna Bonjoch; Roger Paredes; Pere Domingo; Manel Cervantes; Enric Pedrol; Esteban Ribera; Lluís Force; Josep M Llibre; Josep Vilaró; David Dalmau; Josep Cucurull; Jaume Mascaró; Angels Masabeu; Núria Pérez-Alvarez; Jordi Puig; Denise Cinquegrana; Bonaventura Clotet
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
AIDS research and human retroviruses 2006;22(4):321-9.
2006: Francesc Vidal; Joaquim Peraire; Pere Domingo; Montserrat Broch; Mireia Cairó; Enric Pedrol; Milagros Montero; Consuelo Viladés; Cristina Gutiérrez; Maria Antonia Sambeat; Angels Fontanet; David Dalmau; Elisabet Deig; Hernando Knobel; Joan-Josep Sirvent; Cristóbal Richart; Sergi Veloso; Maria Saumoy; Miguel López-Dupla; Montserrat Olona; Josep Cadafalch; Montserrat Fuster; Anna Ochoa; Anna Soler; Ana Guelar; Judit González
Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years.
Journal of acquired immune deficiency syndromes (1999) 2006;41(1):17-22.
2005: Francesc Vidal; Consuelo Viladés; Pere Domingo; Montserrat Broch; Enric Pedrol; David Dalmau; Hernando Knobel; Joaquim Peraire; Cristina Gutiérrez; Maria Antonia Sambeat; Angels Fontanet; Elisabet Deig; Mireia Cairó; Milagros Montero; Cristóbal Richart; Simon Mallal
Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele.
Journal of acquired immune deficiency syndromes (1999) 2005;40(5):527-31.
2005: Emilia Condes; Koldo Aguirrebengoa; David Dalmau; José Manuel Estrada; Lluís Force; Miguel Górgolas; Xavier Badia; Daniel Podzamczer
[Validation of a questionnaire to estimate satisfaction with antiretroviral treatment: CESTA questionnaire].
Enfermedades infecciosas y microbiología clínica 2005;23(10):586-92.
2005: Francesc Vidal; Joaquim Peraire; Pere Domingo; Montserrat Broch; Hernando Knobel; Enric Pedrol; David Dalmau; Consuelo Viladés; Maria Antonia Sambeat; Cristina Gutiérrez; Cristóbal Richart
Lack of association of SDF-1 3'A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 years.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):276-9.
2005: Anna Ochoa de Echagüen; Mireia Arnedo; Mariona Xercavins; Esteban Martinez; Beatriz Rosón; Esteban Ribera; Pere Domingo; Alicia González; Melcior Riera; Josep M Llibre; José M Gatell; David Dalmau
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.
AIDS (London, England) 2005;19(13):1385-91.
2005: Berta Rodes; Federico García; Carolina Gutierrez; Javier Martinez-Picado; Antonio Aguilera; Maria Saumoy; Alex Vallejo; Pere Domingo; David Dalmau; Maria Angels Ribas; José L Blanco; José Pedreira; Maria Jesús Perez-Elias; Manuel Leal; Carmen de Mendoza; Vincent Soriano
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Journal of medical virology 2005;77(1):23-8.
2005: Daniel Podzamczer; Elena Ferrer; José M Gatell; Jordi Niubo; David Dalmau; Agathe Leon; Hernando Knobel; Carolina Polo; Daniel Iniguez; Isaac Ruiz
Early virological failure with a combination of tenofovir, didanosine and efavirenz.
Antiviral therapy 2005;10(1):171-7.
2004: Hernando Knobel; José M Miró; Beatriz Mahillo; Pere Domingo; Antonio Rivero; Esteban Ribera; Juan Gonzalez; José Sanz; Alicia González; José L Blanco; Vicente Boix; Lluís Force; Josep M Llibre; David Dalmau; Juan A Arroyo; Julián De la Torre; Dolors Rodriguez; María Luisa Montes; Alberto Arranz; María Sarasa
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1276-81.
2003: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; Melcior Riera; Enric Pedrol; Lluís Force; Josep M Llibre; Ferran Segura; Cristóbal Richart; Cristina Cortés; Manuel Javaloyas; Miquel Aranda; Anna Cruceta; Elisa De Lazzari; José M Gatell
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
The New England journal of medicine 2003;349(11):1036-46.
2003: Ana Barrios; Carmen de Mendoza; Luz Martín-Carbonero; Esteban Ribera; Pere Domingo; María José Galindo; Juan Gálvez; Vicente Estrada; David Dalmau; Victor Asensi; Vincent Soriano
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.
Journal of clinical microbiology 2003;41(9):4421-3.
2003: Lucia Gomez; Javier Garau; Cristina Estrada; Montserrat Marquez; David Dalmau; Mariona Xercavins; Josep Maria Martí; Cristina Estany
Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Cancer 2003;97(2):419-24.
2001: Oscar Gallego; Carmen de Mendoza; María Jesús Pérez-Elías; J M Guardiola; José Pedreira; David Dalmau; J Gónzalez; A Moreno; José R Arribas; Amalia Rubio; I García-Arata; Manuel Leal; Pere Domingo; Vincent Soriano
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.
AIDS (London, England) 2001;15(13):1701-6.
2000: Felipe García; Hernando Knobel; Maria Antonia Sambeat; Julio Arrizabalaga; Miquel Aranda; Joan Romeu; David Dalmau; Ferran Segura; JL Gomez-Sirvent; Elena Ferrer; Anna Cruceta; Teresa Gallart; Tomás Pumarola; José M Miró; José M Gatell
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan study.
AIDS (London, England) 2000;14(16):2485-94.
2000: Felipe García; M M Alonso; Joan Romeu; Hernando Knobel; Julio Arrizabalaga; Elena Ferrer; David Dalmau; I Ruiz; Francesc Vidal; A Frances; Ferran Segura; JL Gomez-Sirvent; Anna Cruceta; Bonaventura Clotet; Tomás Pumarola; Teresa Gallart; WA O'Brien; José M Miró; José M Gatell
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):26-35.
1999: Felipe García; Joan Romeu; Imma Grau; Maria Antonia Sambeat; David Dalmau; Hernando Knobel; JL Gomez-Sirvent; Julio Arrizabalaga; Anna Cruceta; Bonaventura Clotet; Daniel Podzamczer; Tomás Pumarola; Teresa Gallart; WA O'Brien; José M Miró; José M Gatell
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
AIDS (London, England) 1999;13(17):2377-88.
1999: David Dalmau; Anna Ochoa de Echagüen
[Evaluation of resistance to anti-retroviral agents. Publication of clinical trials].
Enfermedades infecciosas y microbiología clínica 1999;17 Suppl 2():81-5.
1997: David Dalmau; J Castãné; E Alvarez; L Ortega; J Garau
A case of Q fever endocarditis treated medically: 9 years of follow-up.
Infection 1997;25(2):131-2.